Back

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding Imaging ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Asim Katbeh

Harmony Heart Clinic, Damascus (Syrian Arab Republic)

12 More presentations in this session

Presentation thumbnail
Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants
Doctor I. Hammami (Oxford, GB)
Abstract
Presentation thumbnail
Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.
Doctor A. Conti (Massa, IT)
Abstract Slides
Presentation thumbnail
CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area
Doctor A. Baluja (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.
Professor D. Linz (Maastricht, NL)
Abstract
Presentation thumbnail
Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials
Associate Professor M. Proietti (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
How imaging helps prevention
thumbnail
Congress Presentation
How to anticipate myocardial damage after oncologic treatments with imaging techniques
thumbnail
Congress Presentation
Coronary computed tomography (CT) is very precise for risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources